Switch From Lucentis to Avastin Could Save Medicare $18BSwitch From Lucentis to Avastin Could Save Medicare $18B

Medicare could slash $18 billion in spending over the course of 10 years if physicians treated patients with vision-robbing ailments with bevacizumab instead of ranibizumab. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news